These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells. Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211 [TBL] [Abstract][Full Text] [Related]
3. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity. Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653 [TBL] [Abstract][Full Text] [Related]
4. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum. Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313 [TBL] [Abstract][Full Text] [Related]
5. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons. Staub DR; Evans AK; Lowry CA Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469 [TBL] [Abstract][Full Text] [Related]
6. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors. Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910 [TBL] [Abstract][Full Text] [Related]
7. Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine. Porcher C; Juhem A; Peinnequin A; Sinniger V; Bonaz B Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1091-103. PubMed ID: 15637181 [TBL] [Abstract][Full Text] [Related]
8. Urocortins and the regulation of gastrointestinal motor function and visceral pain. Martinez V; Wang L; Million M; Rivier J; Taché Y Peptides; 2004 Oct; 25(10):1733-44. PubMed ID: 15476940 [TBL] [Abstract][Full Text] [Related]
9. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland. Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689 [TBL] [Abstract][Full Text] [Related]
10. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system. Liu S; Gao X; Gao N; Wang X; Fang X; Hu HZ; Wang GD; Xia Y; Wood JD J Comp Neurol; 2005 Jan; 481(3):284-98. PubMed ID: 15593376 [TBL] [Abstract][Full Text] [Related]
11. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity. Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804 [TBL] [Abstract][Full Text] [Related]
12. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system. Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938 [TBL] [Abstract][Full Text] [Related]
13. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2. Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478 [TBL] [Abstract][Full Text] [Related]
14. The effects of CRF and the urocortins on [3H]GABA release from the rat amygdala--an in vitro superfusion study. Bagosi Z; Jászberényi M; Szabó G; Telegdy G Brain Res Bull; 2008 Jan; 75(1):15-7. PubMed ID: 18158090 [TBL] [Abstract][Full Text] [Related]
15. Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala. Amat J; Tamblyn JP; Paul ED; Bland ST; Amat P; Foster AC; Watkins LR; Maier SF Neuroscience; 2004; 129(3):509-19. PubMed ID: 15541873 [TBL] [Abstract][Full Text] [Related]
16. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation. Inada Y; Ikeda K; Tojo K; Sakamoto M; Takada Y; Tajima N Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699 [TBL] [Abstract][Full Text] [Related]
17. Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain. Korosi A; Veening JG; Kozicz T; Henckens M; Dederen J; Groenink L; van der Gugten J; Olivier B; Roubos EW Brain Res; 2006 Feb; 1072(1):46-54. PubMed ID: 16423327 [TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord. Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496 [TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant. Dautzenberg FM; Higelin J; Wille S; Brauns O Regul Pept; 2004 Sep; 121(1-3):89-97. PubMed ID: 15256278 [TBL] [Abstract][Full Text] [Related]
20. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice. Martínez V; Wang L; Rivier J; Grigoriadis D; Taché Y J Physiol; 2004 Apr; 556(Pt 1):221-34. PubMed ID: 14755002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]